Cargando…
Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin
Periprosthetic Joint Infection (PJI) is a significant contributor to patient morbidity and mortality, and it can be addressed through a range of surgical interventions coupled with antibiotic therapies. Following surgical intervention(s), prolonged administration of oral antibiotics is recommended t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668752/ https://www.ncbi.nlm.nih.gov/pubmed/37998762 http://dx.doi.org/10.3390/antibiotics12111560 |
_version_ | 1785139538274811904 |
---|---|
author | Reinecke, Pia Morovic, Paula Niemann, Marcel Renz, Nora Perka, Carsten Trampuz, Andrej Meller, Sebastian |
author_facet | Reinecke, Pia Morovic, Paula Niemann, Marcel Renz, Nora Perka, Carsten Trampuz, Andrej Meller, Sebastian |
author_sort | Reinecke, Pia |
collection | PubMed |
description | Periprosthetic Joint Infection (PJI) is a significant contributor to patient morbidity and mortality, and it can be addressed through a range of surgical interventions coupled with antibiotic therapies. Following surgical intervention(s), prolonged administration of oral antibiotics is recommended to cure PJI. There is a lack of reports on the adverse events (AEs) associated with oral antibiotics, particularly rifampin. This investigation sought to elucidate the occurrence of antibiotic-related AEs after an initial regimen of intravenous antibiotic administration, supplemented by an extended course of oral antibiotics. A prospective study of patients diagnosed with PJI of the hip, knee, or shoulder who underwent single-stage exchange arthroplasty (SSE) (10%), two-stage exchange arthroplasty (TSE) (81%), or debridement, antibiotics, and implant retention (DAIR) (6%) was performed. The primary outcome of interest was the detection of AEs, the secondary outcome the detection of a correlation between rifampin use and the incidence of AEs, and the tertiary outcome was whether oral antibiotic treatment needed to be adjusted or discontinued due to AEs. In addition, subjective tolerability was monitored throughout the study. A total of 336 events were identified for 73 out of 80 patients. The most frequently used antibiotics were rifampin and co-trimoxazole. Most AEs occurred in the gastrointestinal tract (46%). The most frequent AEs were nausea, inappetence, diarrhea, and skin rash. In 6% of cases, the AEs led to antibiotic discontinuation, and in 29% of cases, a dose adjustment of the oral therapy occurred, mainly with amoxicillin or co-trimoxazole. The majority of patients (55%) rated the subjective tolerability as good. In conclusion, AEs during antibiotic treatment for PJI are common. They mainly affect the gastrointestinal tract. Rifampin use might be a reason for the higher incidence of AEs compared to non-rifampin antibiotic treatment. |
format | Online Article Text |
id | pubmed-10668752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106687522023-10-24 Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin Reinecke, Pia Morovic, Paula Niemann, Marcel Renz, Nora Perka, Carsten Trampuz, Andrej Meller, Sebastian Antibiotics (Basel) Article Periprosthetic Joint Infection (PJI) is a significant contributor to patient morbidity and mortality, and it can be addressed through a range of surgical interventions coupled with antibiotic therapies. Following surgical intervention(s), prolonged administration of oral antibiotics is recommended to cure PJI. There is a lack of reports on the adverse events (AEs) associated with oral antibiotics, particularly rifampin. This investigation sought to elucidate the occurrence of antibiotic-related AEs after an initial regimen of intravenous antibiotic administration, supplemented by an extended course of oral antibiotics. A prospective study of patients diagnosed with PJI of the hip, knee, or shoulder who underwent single-stage exchange arthroplasty (SSE) (10%), two-stage exchange arthroplasty (TSE) (81%), or debridement, antibiotics, and implant retention (DAIR) (6%) was performed. The primary outcome of interest was the detection of AEs, the secondary outcome the detection of a correlation between rifampin use and the incidence of AEs, and the tertiary outcome was whether oral antibiotic treatment needed to be adjusted or discontinued due to AEs. In addition, subjective tolerability was monitored throughout the study. A total of 336 events were identified for 73 out of 80 patients. The most frequently used antibiotics were rifampin and co-trimoxazole. Most AEs occurred in the gastrointestinal tract (46%). The most frequent AEs were nausea, inappetence, diarrhea, and skin rash. In 6% of cases, the AEs led to antibiotic discontinuation, and in 29% of cases, a dose adjustment of the oral therapy occurred, mainly with amoxicillin or co-trimoxazole. The majority of patients (55%) rated the subjective tolerability as good. In conclusion, AEs during antibiotic treatment for PJI are common. They mainly affect the gastrointestinal tract. Rifampin use might be a reason for the higher incidence of AEs compared to non-rifampin antibiotic treatment. MDPI 2023-10-24 /pmc/articles/PMC10668752/ /pubmed/37998762 http://dx.doi.org/10.3390/antibiotics12111560 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Reinecke, Pia Morovic, Paula Niemann, Marcel Renz, Nora Perka, Carsten Trampuz, Andrej Meller, Sebastian Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin |
title | Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin |
title_full | Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin |
title_fullStr | Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin |
title_full_unstemmed | Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin |
title_short | Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin |
title_sort | adverse events associated with prolonged antibiotic therapy for periprosthetic joint infections—a prospective study with a special focus on rifampin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668752/ https://www.ncbi.nlm.nih.gov/pubmed/37998762 http://dx.doi.org/10.3390/antibiotics12111560 |
work_keys_str_mv | AT reineckepia adverseeventsassociatedwithprolongedantibiotictherapyforperiprostheticjointinfectionsaprospectivestudywithaspecialfocusonrifampin AT morovicpaula adverseeventsassociatedwithprolongedantibiotictherapyforperiprostheticjointinfectionsaprospectivestudywithaspecialfocusonrifampin AT niemannmarcel adverseeventsassociatedwithprolongedantibiotictherapyforperiprostheticjointinfectionsaprospectivestudywithaspecialfocusonrifampin AT renznora adverseeventsassociatedwithprolongedantibiotictherapyforperiprostheticjointinfectionsaprospectivestudywithaspecialfocusonrifampin AT perkacarsten adverseeventsassociatedwithprolongedantibiotictherapyforperiprostheticjointinfectionsaprospectivestudywithaspecialfocusonrifampin AT trampuzandrej adverseeventsassociatedwithprolongedantibiotictherapyforperiprostheticjointinfectionsaprospectivestudywithaspecialfocusonrifampin AT mellersebastian adverseeventsassociatedwithprolongedantibiotictherapyforperiprostheticjointinfectionsaprospectivestudywithaspecialfocusonrifampin |